Locri, Filippo
Dal Monte, Massimo
Aronsson, Monica
Cammalleri, Maurizio
De Rosa, Mario
Pavone, Vincenzo
Kvanta, Anders
Bagnoli, Paola
André, Helder http://orcid.org/0000-0002-2926-2376
Funding for this research was provided by:
Karolinska Institutet
Kaleyde Pharmaceuticals AG
Article History
Received: 14 November 2018
Revised: 8 April 2019
Accepted: 3 May 2019
First Online: 26 June 2019
Compliance with ethical standards
: Animals were used in accordance with the statement for the Use of Animals in Ophthalmologic and Vision Research and the European Communities Council directive for animals’ use for scientific purposes. Study protocols were approved by Stockholm’s Committee for Ethical Animal Research.
: M.D.R. and V.P. are patent-holders for UPARANT with personal interest in Kaleyde Pharmaceuticals AG. All other authors declare no conflicts of interest.